361 Capital’s Cavium, Inc. CAVM Stock Holding History

361 Capital’s Portfolio CAVM Stock Details CAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-650	Closed	-$38K	–	177
2016 Q3	$38K	Buy	+650	New	+$32.5K	0.35%	40

Other funds holding CAVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AIM

abrdn Investment Management Edinburgh, United Kingdom $29.6B AUM 25.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

361 Capital's CAVM Position: Q4 2016 in Review

361 Capital sold out of Cavium, Inc. (CAVM) in Q4 2016, closing a stake of 650 shares — an estimated $38K sold.

361 Capital first reported a position in CAVM in Q3 2016 and held it in 1 quarter. The position peaked at $38K in Q3 2016. 230 funds tracked by Wall St. Rank hold CAVM as of Q4 2016.

361 Capital reported no remaining Cavium, Inc. position as of Q4 2016 after selling out during the quarter.
361 Capital sold 650 Cavium, Inc. shares in Q4 2016, an estimated $38K.
361 Capital first reported a position in Cavium, Inc. in Q3 2016 and held it in 1 quarter.
361 Capital's Cavium, Inc. position peaked at $38K in Q3 2016.
230 funds tracked by Wall St. Rank held Cavium, Inc. as of Q4 2016.

Based on 361 Capital's 13F filing for Q4 2016, filed 14 Feb 2017.